Gilead Sciences, Inc., is an American biotechnology company that researches, develops and commercializes drugs. The company focuses primarily on antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C, and influenza, including Harvoni and Sovaldi.

Headquartered and founded in Foster City, California, Gilead is a member of the NASDAQ Biotechnology Index and the S&P 500.

Click to see more
Gilead Sciences, Inc. News
GILD Stock Dips by 2.15%, Despite Reporting Profitable Q3 Earnings
By October 29th, 2020
Business News, Market News, News GILD Stock Dips by 2.15%, Despite Reporting Profitable Q3 Earnings
By October 29th, 2020

Gilead Sciences Inc, the American biopharmaceutical company behind the only approved drug for the treatment of COVID-19 known as Remdesivir (or Veklury) has released its third-quarter earnings in which the company posted better than expected earnings. Per the figures posted, GILD reported product sales of $6.5 billion, an 18% increment year-over-year.